Andreas Jahn

Characterizing HIV Acquisition Risk, Treatment Gaps, and Populations Reached Through Venue-Based Outreach and Clinical Services in Blantyre, Malawi: Findings From a District-wide CLOVE Study

Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study

Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models

Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000–20: a modelling study using survey and HIV testing programme data

What is the optimum time to start antiretroviral therapy in people with HIV and tuberculosis coinfection? A systematic review and meta‐analysis

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines

Emerging priorities for HIV service delivery

Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi

Cost‐per‐diagnosis as a metric for monitoring cost‐effectiveness of <scp>HIV</scp> testing programmes in low‐income settings in southern Africa: health economic and modelling analysis

Optimizing <scp>HIV</scp> testing services in sub‐Saharan Africa: cost and performance of verification testing with <scp>HIV</scp> self‐tests and tests for triage

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study

HIV and tuberculosis in prisons in sub-Saharan Africa

Scale-up of ART in Malawi has reduced case notification rates in HIV-positive and HIV-negative tuberculosis

Modelling the Contributions of Malaria, HIV, Malnutrition and Rainfall to the Decline in Paediatric Invasive Non-typhoidal Salmonella Disease in Malawi

Monitoring treatment outcomes in patients with chronic disease: lessons from tuberculosis and <scp>HIV</scp>/<scp>AIDS</scp> care and treatment programmes

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi

Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study

Improved Retention of Patients Starting Antiretroviral Treatment in Karonga District, Northern Malawi, 2005–2012

Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment

Incidence of Pregnancy Among Women Accessing Antiretroviral Therapy in Urban Malawi: A Retrospective Cohort Study

Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?

Very Early Anthropometric Changes After Antiretroviral Therapy Predict Subsequent Survival, in Karonga, Malawi